The strength of our partnerships is helping us discover new and innovative ways to advance healthcare.
The Atlantic Clinical Trials Unit, led by Nova Scotia Health and co-led with IWK Health, Eastern Health, Vitalité Health Network, Horizon Health Network, and Health PEI, is boosting research and innovation, introducing new healthcare opportunities, and positioning the region as a world-leader in clinical trials. ACTN is increasing patient access to trial opportunities and leading care by reducing barriers and burdens associated with clinical trial participation. Learn more.
Nova Scotia Health’s research team in Respirology, which is supported by our Clinical Trials Unit, has been a key partner with Vertex Pharmaceuticals on clinical trials for cystic fibrosis treatments since 2010. This has led to the development of Trikafta, a new drug which has been referred to as the biggest innovation in cystic fibrosis treatment. Read the full story.
